medpundit |
||
|
Tuesday, February 08, 2005U.S. regulators have given conditional approval to Cyberonics Inc.'s bid to sell an implanted device to treat chronic depression, the company said Wednesday, sending its shares up over 30 percent. Houston-based Cyberonics (Research) said it expects full U.S. Food and Administration approval by May. The VNS Therapy System is a pacemaker-like device implanted in the chest that delivers electrical impulses to the brain through an electrode attached to a nerve in the neck. Cyberonics already sells the implant for reducing seizures from epilepsy. It costs about $20,000, including surgical and hospital expenses, said Cyberonics Chief Executive Skip Cummins. More info here. posted by Sydney on 2/08/2005 09:36:00 PM 0 comments 0 Comments: |
|